A. Elise van Leeuwen‐Stok
Breast Cancer Research Foundation(US)Dutch Colorectal Cancer Group(NL)Borstkankervereniging Nederland(NL)SWOG Cancer Research Network(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cancer Cells and Metastasis, Immunotherapy and Immune Responses, Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies
Most-Cited Works
- → Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study(2015)375 cited
- → Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial(2020)326 cited
- → Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)(2017)199 cited
- → Baseline comprehensive geriatric assessment is associated with toxicity and survival in elderly metastatic breast cancer patients receiving single-agent chemotherapy: Results from the OMEGA study of the Dutch Breast Cancer Trialists' Group(2013)134 cited
- → Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).(2023)89 cited